Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast
Request for Sample Report: http://www.mrrse.com/sample/931
The Diabetes Diagnostic Devices and drugs market has been segmented based on devices and drugs available for the treatment the disease. Based on device type, the market is segmented into diabetes diagnostic devices and insulin delivery devices. Diabetes diagnostic devices include analog blood meter, test strips, lancets and lancing devices, continuous glucose monitoring devices and others. The insulin delivery devices segment include insulin syringes, insulin pens, insulin pumps and insulin injectors.
Based on drugs, the market is segmented into insulin derivatives, oral anti-diabetes drugs and non-insulin injectable anti-diabetes drugs. The insulin derivatives segment is further categorized as rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. The oral anti-diabetes drugs segment includes various drugs classes such as sulphonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors, GPP-4 inhibitors and SGLT-2 inhibitors. The non-insulin injectable anti-diabetes drugs segment is segmented into GLP-1 analogs and Pramlintide. The market for these devices and drugs has been extensively analyzed based on demand for branded and generic products in each class of drugs and devices. Rising prevalence of diabetic population across various regions of the world, pipeline products from each class, rising preference of patients and healthcare professionals toward technologically advanced monitoring and insulin delivery devices is driving the growth of the diabetes diagnostic devices and drugs market.
Make an Enquiry: http://www.mrrse.com/enquiry/931
The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The diabetes devices and drugs market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
Geographically, the diabetes diagnostic devices and drugs market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019, along with the CAGR (%) for the forecast period 2013 to 2019. The diabetes diagnostic devices and drugs market study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises a qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis and market attractiveness analysis. In addition, thorough analyses of various events, which occurred in the past five years and are expected to occur during forecast period, are also provided in the market overview section of the report. In this section, the major events, which affected the market and are expected to affect the market are studied. Further, value chain analysis (VCA) for drugs and devices is also provided, which highlights the major stages of the development of drugs and devices. The entire section of market overview plays an important role in understanding the market on a global level.
The diabetes devices and drugs market report also provides a highlight of the competitive landscape of the market wherein the market share analysis of the leading players in the diabetes devices and drugs market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the diabetes devices and drugs market such as Abbott Laboratories, Inc., AstraZeneca plc, B Braun Melsungen AG, Bayer HealthCare AG, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Sanofi, and Takeda Pharmaceutical Company Limited. Market players are profiled based on attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
Browse Full Report with TOC: http://www.mrrse.com/diabetes-devices-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Follow Us on LinkedIn-https://www.linkedin.com/company/mrrse
Follow Us On Twitter-https://twitter.com/MRRSEmrrse
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast here
News-ID: 578215 • Views: …
More Releases from Industry Research Reports - MRRSE
ECG Systems Industry- Global Market Analysis, Size, Share, Growth, Trends, and F …
Recently, the medical diagnostic sector for electrocardiogram (ECG) which detects heart problems has seen a surge in business, due to the global rise in lifestyle disorders like diabetes and obesity. This test investigates the real cause for anginas, chest pains, heart attacks, symptoms of heart diseases, and even issues with pacemakers, high blood pressure and early heart diseases. A new study is added to the vast repository of Market Research
Global Market Study on Enterprise Governance, Risk and Compliance (EGRC)-MRRSE
Enterprise governance, risk and compliance (EGRC) being a multifaceted and innovative approach to risk management, corporate governance and compliance issues has a direct impact on business objectives. Market Research Reports Search Engine (MRRSE) has recently publicized the addition of a new research report to its vast online repository with a title “Enterprise Governance, Risk and Compliance (EGRC) Market: Global Industry Analysis and Forecast, 2016-2024”. This report on global enterprise governance, risk and
Global Market Study on Cable Cars & Ropeways :Growing Preference for Elevators a …
With a rise in global GDP, disposable income of people has also increased. People are now capable of spending a significant share of their earnings in amusement and leisure activities. Considering this scenario, Market Research Reports Search Engine (MRRSE) has recently publicized the addition of a new market report to its vast online repository with a title “Cable Cars and Ropeways Market: Global Industry Analysis and Forecast, 2016-2024”. This report
Metal Oxide Varistor (MOV) Market - Global Industry Analysis, Size, Share, Growt …
The global market for metal oxide varistor (MOV) is deriving much of its growth from the rising popularity of Internet of Things (IoT) and the upsurge in its adoption in automobile applications. A new research report titled as “Metal Oxide Varistor (MOV) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025” has been recently added to the huge portfolio of Market Research Reports Search Engine (MRRSE) online
More Releases for Diabetes
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025. Research and Development Pursuits to Introduce Novel Products Stokes Growth The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food